Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-potency marijuana impairs executive function and inhibitory motor control.

Johannes G Ramaekers1, Gerhold Kauert, Peter van Ruitenbeek

  • 1Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology, Maastricht University, Maastricht, The Netherlands. j.ramaekers@psychology.unimaas.nl

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|March 31, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Psychopharmacology·2026
Same author

Evaluating the evidence for repressed memory recovery in psychedelic contexts.

Psychopharmacology·2026
Same author

Brain-body integromics of the ayahuasca experience.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

Molecular psychiatry·2026
Same author

An international mega-analysis of psychedelic drug effects on brain circuit function.

Nature medicine·2026
Same author

<i>In Vivo</i> Detection of Nitrous Oxide in Blood and Saliva Following Recreational Use.

ACS omega·2026

High-potency marijuana (13% THC) significantly impairs cognitive and motor functions for up to six hours. This study used higher doses than previous research to better understand THC-induced impairment.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Human Performance Research

Background:

  • Previous human performance studies on marijuana impairment predominantly used low-potency products (e.g., 4% THC).
  • The effects of high-potency marijuana (13% THC) on cognitive and motor performance remain less understood.
  • Understanding THC-induced impairment is crucial for public safety and policy development.

Purpose of the Study:

  • To assess the impact of high-potency marijuana (13% THC) on various human performance domains.
  • To compare the effects of different doses of THC (250 and 500 µg/kg) on performance.
  • To determine the duration of THC-induced performance deficits.

Main Methods:

  • A double-blind, placebo-controlled, three-way crossover study involving 20 recreational marijuana users.

Related Experiment Videos

  • Administration of single doses of 0, 250, and 500 µg/kg THC.
  • Assessment of motor control (Critical tracking task), executive function (Tower of London), motor impulsivity (Stop signal task), and risk-taking (Iowa gambling task) at regular intervals up to 6 hours post-smoking.

    • Main Results:

    • THC significantly impaired performance on the Critical tracking task and reduced correct decisions in the Tower of London task.
    • THC increased stop reaction time and errors (commission and omission) in the Stop signal task.
    • Performance impairments persisted for up to 6 hours, with dose-dependent effects observed (higher dose yielded greater impairment).

    Conclusions:

    • High-potency marijuana (13% THC) consistently impairs executive function and motor control in humans.
    • The duration of impairment can extend up to 6 hours post-consumption.
    • Utilizing higher THC doses in controlled studies provides a more reliable measure of THC-induced impairment compared to lower doses.